drugset / Trial / NCT02537899

Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD

NCT02537899 ↗

Phase 4 Completed 30 enrolled Moleac Pte Ltd.
NaSingle-groupOpen-labelTreatment

Summary

SATURN investigates the promising role of NeuroAiD in patients with spinal cord injury and will provide important information on the feasibility of conducting larger controlled trials.

Timeline

Start
2015-04
Primary completion
2023-09-20
Completion
2023-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject NeuroAiD Traditional medicine (herbal / TCM) — —

Indications